Pharma Third Party Manufacturing

Product Details:

Vildagliptin is an oral DPP-4 inhibitor approved for the treatment of type 2 diabetes. By inhibiting DPP-4 and increasing GLP-1 levels, it results in higher insulin levels and lower glucose levels, particularly after eating

Additional Information:

• Production Capacity: 1100000
• Delivery Time: SAME TIME
• Packaging Details: 10X15